TITLE

DEEP VEIN THROMBOSIS TREATED WITH STREPTOKINASE OR HEPARIN

AUTHOR(S)
Seaman, Arthur J.; Common, Herbert H.; Rösch, Josef; Dotter, Charles T.; Porter, John M.; Lindell, Thomas D.; Lawler, William L.; Schlueter, William J.
PUB. DATE
October 1976
SOURCE
Angiology;Oct1976, Vol. 27 Issue 10, p549
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Randomly assigned streptokinase or heparin therapy was studied in 50 patients with deep vein thrombosis of less than 2 weeks' duration. Venography was performed prior to therapy, after 3 days, and after 10 days. Two radiologists who were unaware of the patient's therapy compiled a single average lytic score for each patient at each time interval. Lysis of venous thrombi was significantly greater with streptokinase than with heparin after 3 days, but not after 10 days of treatment. Lytic scores achieved with streptokinase were significantly better than those achieved with heparin therapy (P < .01) in male patients who were symptomatic for 3 days or less. In females, regardless of the duration of symptoms, thrombolytic results obtained with streptokinase were not significantly different than results obtained with heparin.
ACCESSION #
16352564

 

Related Articles

  • Prophylactic use of LMWH plus intermittent pneumatic compression prevented DVT in hip or knee arthroplasty. Eikelboom, John W. // Evidence Based Medicine;Apr2005, Vol. 10 Issue 2, p48 

    The article cites a research study, which reveals that prophylactic use of low-molecular-weight heparin (LMWH) plus intermittent pneumatic compression prevented deep vein thrombosis (DVT) in hip or knee arthroplasty. The researchers concluded that in patients who have total hip or total knee...

  • Management of Thrombotic and Cardiovascular Disorders in the New Millenium. Fareed, Jawed; Hoppensteadt, Debra A.; Bick, Rodger L. // Clinical & Applied Thrombosis/Hemostasis;Apr2003, Vol. 9 Issue 2, p101 

    Anticoagulants and antithrombotic drugs have played a key role in the prophylaxis, treatment and surgical/interventional management of thrombotic and cardiovascular disorders. There are several newer drugs which are currently developed for the anticoagulant management of cardiovascular diseases...

  • THE EFFECT OF SREPTOKINASE ON THE PLATELET AGGREGATES IN ARTIFICIAL IN VITRO THROMBOSIS. Rozenberg, M.C. // Australian Journal of Experimental Biology & Medical Science;Jun1965, Vol. 43 Issue 3, p245 

    A cone-in-cone rotational viscometer is used to produce artificial in vitro thrombosis and lysis is stimulated with streptokinase. It is shown that the voagula lyse, but platelet masses in these remain unaffected. The implications of this finding are discussed with regard to the knowledge of...

  • streptokinase. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p716 

    An encyclopedia entry for "streptokinase" is presented. It refers to a thrombolytic drug that dissolves blood clots in myocardial infarction or heart attack and pulmonary embolism, a condition where a clot blocks a blood vessel in the lung. The side effects of the drug includes excessive...

  • Use of Artificial Neural Networks to Examine Parameters Affecting the Immobilization of Streptokinase in Chitosan. Sadegh Modaresi, Seyed Mohamad; Ali Faramarzi, Mohammad; Soltani, Arash; Baharifar, Hadi; Amani, Amir // Iranian Journal of Pharmaceutical Research;2014, Vol. 13 Issue 4, p1377 

    Streptokinase is a potent fibrinolytic agent which is widely used in treatment of deep vein thrombosis (DVT), pulmonary embolism (PE) and acute myocardial infarction (MI). Major limitation of this enzyme is its short biological half-life in the blood stream. Our previous report showed that...

  • Trombosis de la arteria renal en un recién nacido. Presentación de un caso y revisión. Torres, Ana Lucía; Torres, Javier; Cifuentes, Jorge Andrés // Colombia Medica;ene-mar2009, Vol. 40 Issue 1, p114 

    This report describes a newborn who presents high pressure values and absence of pulses in inferior extremities in his 4th day of life. Posterior to placement of umbilical arterial catheter, confirming diagnostic of thrombosis in aorta and left renal artery. A gamagraphy with MAG 3 was performed...

  • Heparin Reduces DVT with Transvenous Pacemakers. Sadovsky, Richard // American Family Physician;3/1/2002, Vol. 65 Issue 5, p939 

    Presents information on a study by P. Sanders and others to quantitate the risk of lower limb deep venous thrombosis in patients requiring temporary transfemoral pacing and to evaluate the use of heparin in thrombus prevention. Description of the study and its results; Conclusion that deep...

  • INRs and point of care testing. Murray, E. T.; Greaves, M. // BMJ: British Medical Journal (International Edition);7/5/2003, Vol. 327 Issue 7405, p5 

    Reports on the development and adoption of instruments for determining the international normalised ratio (INR) at the point of care for monitoring treatment with coumarin anticoagulants. Use of coumarin anticoagulants in the treatment of thrombosis; How a difference exists between the...

  • Development of 67Ga-labeled streptokinase. Jalilian, Amir Reza; Mirazizi, Fatemeh; Nazem, Habibolah // Pharmaceutical Chemistry Journal;Jun2009, Vol. 43 Issue 6, p287 

    Radiolabeled streptokinase can be used in the imaging of thrombi in many cardiovascular diseases. Streptokinase was successively labeled with [67Ga]-gallium chloride using cyclic DTPA-dianhydride followed by biodistribution studies in wild-type and thrombosis-induced mice using scarification and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics